NCT03510156View on ClinicalTrials.gov

Treatment of Disruptive Behaviors in Fragile X Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Fragile X SyndromeDisruptive Behavior
Interventions
BEHAVIORAL

Behavior analytic treatment

Function-based treatment

Trial Locations (1)

94305

Department of Psychiatry and Behavioral Sciences, Stanford

All Listed Sponsors
collaborator

The John Merck Fund

UNKNOWN

lead

Stanford University

OTHER

NCT03510156 - Treatment of Disruptive Behaviors in Fragile X Syndrome | Biotech Hunter | Biotech Hunter